⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AQST News
Aquestive Therapeutics, Inc. Common Stock
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
globenewswire.com
AQST
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
globenewswire.com
AQST
AQST FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026
businesswire.com
AQST
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
AQST
AQST EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AQST
Pomerantz LLP Notifies Shareholders of Class Action Lawsuit Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST
AQST DEADLINE - FINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Aquestive Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit Today
accessnewswire.com
AQST
AQST Deadline: AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
AQST
AQST DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST
accessnewswire.com
AQST
Pomerantz LLP Notifies Shareholders of Class Action Filing Against Aquestive Therapeutics, Inc. – AQST
accessnewswire.com
AQST